Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Gedian Humanwell Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of reproductive health medications and steroid hormones. As a core subsidiary of Humanwell Healthcare, the company is a leading provider of emergency contraceptives and fertility control products in the Chinese market. Its product portfolio includes high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, with a strong focus on steroid hormones, central nervous system drugs, and antiviral medications. The company operates large-scale, GMP-certified manufacturing facilities and exports its products to numerous international markets, including Southeast Asia, Europe, and the Americas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Gedian Renfu Pharmaceutical.